Marc Cobo

SVP, Finance & CAO, Tricida.

Companies

BridgeBio Oncology Therapeutics, Inc.Principal Accounting Officer Apr 30, 2026 to now¹
TricidaSVP, Finance & CAO Jul 1, 2020 to Sep 14, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

BridgeBio Oncology Therapeutics, Inc. BBOT14,141 shares³$39.7K at $2.81Sep 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 10, 2026Shares withheld for tax 203 shares at $5.52 of BridgeBio Oncology Therapeutics, Inc.³
Sep 10, 2026Granted 9,038 shares of BridgeBio Oncology Therapeutics, Inc.³
Jul 1, 2026Shares withheld for tax 125 shares at $7.80 of BridgeBio Oncology Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBridgeBio Oncology Therapeutics, Inc., Principal Accounting Officer
2
SEC EDGARTricida, SVP, Finance & CAO
3
SEC EDGARBridgeBio Oncology Therapeutics, Inc. shares after the filing of Sep 10, 2026
4
SEC EDGARForm 4 filed Jul 6, 2026